Allianz Asset Management Gmb H Selecta Biosciences Inc Transaction History

Allianz Asset Management Gmb H

  • $69.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 13, 2018
SELL
$9.36 - $13.25 $454,643 - $643,592
-48,573 Closed
0 $0
Q1 2018

May 14, 2018
SELL
$8.49 - $11.82 $7,233 - $10,070
-852 Reduced 1.72%
48,573 $495,000
Q4 2017

Feb 13, 2018
BUY
$8.97 - $23.38 $443,342 - $1.16 Million
49,425
49,425 $485,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email